These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 33579547)

  • 1. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
    Jhaveri R
    Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-induced protection in aging adults and pandemic response.
    Schenkelberg T
    Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19.
    Li Q; Wang J; Tang Y; Lu H
    Drug Discov Ther; 2021; 15(3):118-123. PubMed ID: 34234059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 9. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccines: one step towards the beginning of the end of the global impact of the pandemic.
    Cook TM; Farrar JJ
    Anaesthesia; 2021 Apr; 76(4):435-443. PubMed ID: 33316853
    [No Abstract]   [Full Text] [Related]  

  • 11. The COVID-19 exit strategy-why we need to aim low.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Mar; 21(3):297. PubMed ID: 33581748
    [No Abstract]   [Full Text] [Related]  

  • 12. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 15. The Next Set of COVID-19 Vaccines: Leveraging New Development Platforms to Increase Access for More People Around the World.
    Jhaveri R
    Clin Ther; 2021 Apr; 43(4):702-710. PubMed ID: 33832783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-Point Action Agenda to End the COVID-19 Pandemic for President-elect Biden.
    Gostin LO
    JAMA; 2021 Jan; 325(1):17-18. PubMed ID: 33399836
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
    Forman R; Shah S; Jeurissen P; Jit M; Mossialos E
    Health Policy; 2021 May; 125(5):553-567. PubMed ID: 33820678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccination in Ukraine.
    Holt E
    Lancet Infect Dis; 2021 Apr; 21(4):462. PubMed ID: 33773128
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum.
    Vashishtha VM; Kumar P
    Indian J Med Ethics; 2021; VI(1):1-3. PubMed ID: 34080991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.